Skip to content

Advertisement

BMC Infectious Diseases

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease

  • Jim Young1Email author,
  • Nina Weis2,
  • Harald Hofer3,
  • William Irving4,
  • Ola Weiland5,
  • Emiliano Giostra6,
  • Juan Manuel Pascasio7,
  • Lluis Castells8,
  • Martin Prieto9,
  • Roelien Postema10,
  • Cinira Lefevre11,
  • David Evans11,
  • Heiner C. Bucher1 and
  • Jose Luis Calleja12
BMC Infectious DiseasesBMC series – open, inclusive and trusted201717:45

https://doi.org/10.1186/s12879-016-2106-x

Received: 28 May 2016

Accepted: 10 December 2016

Published: 7 January 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
28 May 2016 Submitted Original manuscript
1 Aug 2016 Reviewed Reviewer Report - Vanni Borghi
7 Aug 2016 Reviewed Reviewer Report - Valeria Miranda Avanzi
12 Aug 2016 Reviewed Reviewer Report - Anders Boyd
13 Nov 2016 Author responded Author comments - Jim Young
Resubmission - Version 2
13 Nov 2016 Submitted Manuscript version 2
19 Nov 2016 Reviewed Reviewer Report - Anders Boyd
8 Dec 2016 Author responded Author comments - Jim Young
Resubmission - Version 3
8 Dec 2016 Submitted Manuscript version 3
Publishing
10 Dec 2016 Editorially accepted
7 Jan 2017 Article published 10.1186/s12879-016-2106-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland
(2)
Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark
(3)
Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
(4)
NIHR Nottingham Digestive Diseases Biomedical Research Unit, University of Nottingham, Nottingham, UK
(5)
Division of Infectious Diseases, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
(6)
Service de Gastroentérologie et Hépatologie, Hôpitaux universitaires de Genève, Geneva, Switzerland
(7)
Hospital Universitario Virgen del Rocío, Seville, Spain
(8)
Liver Unit, Internal Medicine Department, Hospital Universitari Vall Hebron, Barcelona, Spain
(9)
Hepatology Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain
(10)
Worldwide Health Economics and Outcomes Research, Bristol-Myers Squibb, Uxbridge, United Kingdom
(11)
Worldwide Health Economics and Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France
(12)
Liver Unit, Hospital Universitario Puerta de Hierro, Universidad Autonoma de Madrid, Madrid, Spain

Advertisement